HSGX - Histogenics Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
9,919
15,634
15,566
21,577
23,243
Selling General and Administrative
10,114
10,204
9,384
8,530
8,266
Total Operating Expenses
20,033
25,838
24,950
30,107
31,509
Operating Income or Loss
-20,033
-25,838
-24,950
-30,107
-31,509
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
17,933
17,765
-1,598
17,059
-382
Income Before Tax
-2,684
-8,643
-26,414
-16,208
-32,024
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-2,684
-8,643
-26,414
-16,208
-32,024
Net Income
-2,684
-8,643
-26,414
-16,208
-32,024
Net Income available to common shareholders
-3,023
-8,522
-22,499
-13,863
-32,024
Reported EPS
Basic
-
-13.80
-59.40
-58.20
-145.20
Diluted
-
-47.40
-59.40
-130.80
-145.20
Weighted average shares outstanding
Basic
-
607
378
238
221
Diluted
-
618
378
240
221
EBITDA
-
-25,388
-23,416
-28,434
-29,895